Prenatal COVID exposure showed no broad link to child neurodevelopment
A Norwegian study of 204,663 children found no raised risk of autism or most neurodevelopmental disorders after maternal COVID in pregnancy — with one exception in the early pandemic.
| Group | Value (value) |
|---|---|
| Any neurodevelopmental | 0.97 (0.88 to 1.08) |
| Autism | 0.88 (0.67 to 1.15) |
| Speech/language | 1.13 (0.8 to 1.59) |
| Epilepsy | 1.14 (0.87 to 1.48) |
Early in the pandemic, a plausible worry took hold: that a mother's COVID-19 infection might disturb fetal brain development, given how maternal infection and inflammation are linked to neurodevelopmental risk in general. A cohort study published on 3 September in JAMA Network Open, drawing on Norway's national registries, offers one of the larger and longer-followed tests of that worry — and its answer is broadly reassuring [s1].
What the study did
The researchers included all children born in Norway between 1 March 2020 and 31 December 2023 who reached at least 22 gestational weeks and 500 g birth weight [s1]. Prenatal COVID exposure was defined by a positive PCR test for SARS-CoV-2 in the mother between conception and delivery, drawn from the national communicable-disease surveillance system, and outcomes were pulled from the Norwegian Patient Registry [s1]. They tracked eight outcomes: any neurodevelopmental disorder, autism, developmental speech or language disorders, developmental motor disorders, intellectual disorders, any neurological disorder, epilepsy, and sensory impairments [s1]. Risks were estimated with Cox proportional-hazards regression [s1].
Of 204,663 children (51.2% male), 16,325 — 8.0% — were exposed to maternal COVID during pregnancy [s1].
What it found
Across the board, exposed children showed no statistically significant increase in risk. The adjusted hazard ratios hovered around 1.0: any neurodevelopmental disorder 0.97 (95% CI, 0.88–1.08), autism 0.88 (95% CI, 0.67–1.15), speech or language disorders 1.13 (95% CI, 0.80–1.59), motor disorders 0.83 (95% CI, 0.44–1.56), intellectual disorders 1.19 (95% CI, 0.65–2.19), any neurological disorder 0.97 (95% CI, 0.88–1.07), epilepsy 1.14 (95% CI, 0.87–1.48) and sensory impairments 1.09 (95% CI, 0.92–1.30) [s1]. Every one of those confidence intervals crosses 1.0, the threshold below which an association would be reliable [s1]. The findings held across sensitivity analyses and did not vary by trimester of exposure or by the dominant circulating variant [s1].
There was one exception. When the analysis excluded children born after 1 March 2022 — a step taken to limit misclassification once SARS-CoV-2 testing became less available — exposed children showed an increased risk of speech or language disorders (adjusted hazard ratio, 2.22; 95% CI, 1.44–3.41) [s1].
How to read the exception
That lone positive result deserves neither dismissal nor alarm. It emerged only in a sensitivity analysis restricted to the early pandemic, when testing patterns differed and confirmed infections may have skewed toward more severe or more carefully tracked cases [s1]. The authors present it as a finding to be replicated, not a settled effect — and it sits against a wall of null results for the same and related outcomes [s1]. Reading a single subgroup signal as the real story, while ignoring the consistent nulls, is exactly the misinterpretation the full dataset guards against.
The study's strengths are its size, its complete national registry follow-up, and its pre-specified list of eight outcomes. Its limits are those of any registry cohort: diagnoses depend on children actually presenting and being coded, follow-up for the youngest children is still short, and PCR-based exposure misses infections that were never tested. The authors call for replication in other populations [s1].
Why it matters
For parents who had COVID during pregnancy, the practical takeaway is that this large study found no broad elevation in neurodevelopmental or neurological risk in their children [s1]. For researchers, the early-pandemic speech-and-language signal is a lead worth chasing rather than a conclusion. As with all observational work, an absence of detected risk is not a guarantee of no risk — but a null this large and this consistent is meaningful evidence in its own right.
This article is informational and does not constitute medical advice.
Sources
- [s1] Prenatal COVID-19 Exposure and Neurodevelopmental and Neurological Disorders in Children. JAMA Network Open, 3 September 2026. https://doi.org/10.1001/jamanetworkopen.2026.31847
Sources
- Prenatal COVID-19 Exposure and Neurodevelopmental and Neurological Disorders in Children — JAMA Network Open , September 3, 2026
More on
Higher pre-pregnancy weight tracks with offspring heart disease decades on
In 2.5 million Swedish births followed to adulthood, mothers' early-pregnancy obesity was linked to a stepwise rise in offspring cardiovascular disease, though sibling analyses temper the size.
Autism's four-to-one sex ratio may be an artefact of when girls get diagnosed
A Swedish birth cohort of 2.76 million people found the cumulative male-to-female ratio for autism incidence had fallen to 1.2 by age 20 — and projects parity by 2024.
Intellectual disability fell across South America. Autism diagnoses barely moved.
A single-author analysis of Global Burden of Disease estimates finds the region's neurodevelopmental picture split in two — and argues the flat autism curve reflects diagnostic capacity, not risk.
US study links several abortion restrictions to worse infant health outcomes
Analysing 64.8 million births from 2005 to 2022, researchers found policies such as physician-only requirements and 20-week bans tied to higher odds of preterm birth or low Apgar scores.